Comparison of two immunoassays for the measurement of serum HE4 for ovarian cancer

INTRODUCTION: The use of Human Epididymis Protein 4 (HE4) as a biomarker for ovarian cancer is gaining traction, providing the impetus for development of a high throughput automated HE4 assay that is comparable to the conventional manual enzyme immunometric-assay (EIA). The aim of this study was to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pract Lab Med
Hauptverfasser: Barr, Chloe E., Funston, Garth, Mounce, Luke T.A., Pemberton, Phillip W., Howe, Jonathon D., Crosbie, Emma J.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Elsevier 2021
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8138765/
https://ncbi.nlm.nih.gov/pubmed/34036134
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.plabm.2021.e00235
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge